Koh Young gets OK from FDA for brain surgery robot

Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...

JLK gets OK from FDA for ICH diagnosis solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...

Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

JLK gets FDA OK for prostate cancer diagnosis AI solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...

Samsung Bioepis gets OK to sell Stelara biosimilar in Europe

South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...

Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

MedPacto gets FDA OK for colorectal cancer drug clinical trial

South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...

Gencurix gets FDA OK for breast cancer prognosis analysis device

South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...

Samsung Bioepis gets FDA OK for its interchangeable biosimilar

Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...

Korea’s antitrust body grants conditional OK to Broadcom-VMware deal

South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...

Daewoong Pharma's GER drug gets product OK from Mexico

South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...

Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

US OKs Chinese-made solar modules using materials of S.Korea's OCI

The US has approved the import of Chinese-made solar panels using polysilicon from South Korea's green and energy company OCI Holdings Co.Pundits sa...

Daewoong to develop eye drops for diabetic retinopathy

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

Celltrion gets OK partial approval for phase 3 of biosimilar in Europe

South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...

JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan

South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...

ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

Ildong Bioscience gets US FDA OK for probiotic raw materials

South Korea's Ildong Bioscience on Thursday said two of its probiotic raw materials received the certification generally recognized as safe (GRAS) f...

SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada

South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...

S.Korea's shipyards get OK from shipping companies to delay vessel delivery

South Korean shipbuilders are breathing a sigh of relief despite the postponed delivery of their container ships due to a chronic shortage of domest...

HD Hyundai develops S.Korea's first offshore supply base for ammonia

HD Hyundai Co., the largest shipbuilding conglomerate in South Korea on Wednesday said it developed for the first time in the country a vessel for s...

Korea Shinhan Financial taps banking unit head as group CEO

Shinhan Financial Group appointed the head of its flagship banking unit as the group’s next chief executive officer as the major South Korean ...

S-Oil to OK $6 billion Shaheen project as Saudi prince heads to Seoul

S-Oil Corp., the South Korean unit of Saudi Arabian Oil Co., will approve the much-touted 8 trillion won ($6 billion) Shaheen project to expand its ...

Hong Kong-based Crypto.com acquires South Korean exchange OK-BIT

Hong Kong-based Crypto.com announced Monday it finalized the acquisition of a 100% stake in South Korea’s cryptocurrency exchange operator OK-...

Chips, forex gains shore up Samsung's Q2 earnings

Samsung Electronics Co.’s second-quarter earnings remained steady compared to three months before, with robust memory chip sales for data cent...

LG shareholders approve spin-off plan amid activist opposition

Shareholders of LG Corp., the holding company of South Korea’s fourth-largest conglomerate LG Group, on Friday gave the nod to the company's p...